Singapore markets open in 5 hours 48 minutes

ITCI Nov 2024 100.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.95000.0000 (0.00%)
As of 01:30PM EDT. Market open.
Full screen
Previous close1.9500
Open1.9500
Bid0.2000
Ask3.1000
Strike100.00
Expiry date2024-11-15
Day's range1.9500 - 1.9500
Contract rangeN/A
Volume2
Open interest500
  • GlobeNewswire

    Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

    NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 45th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2024 at 10:00 a.m. ET in Miami, FL. The live and archived webcast can be accessed und

  • Zacks

    Why Is Intra-Cellular (ITCI) Up 1.2% Since Last Earnings Report?

    Intra-Cellular (ITCI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • GlobeNewswire

    Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

    NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 11:00 a.m. ET in New York, NY. The live and archived webcast can be accessed under "Events &